Jiacheng Yuan

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

Philip J. Mease, Iain B. McInnes, Bruce Kirkham et al. · New England Journal of Medicine · 2015 · 723 citations · Full text

Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design

Quentin M. Anstee, Brent A. Neuschwander‐Tetri, Vincent Wai‐Sun Wong et al. · Contemporary Clinical Trials · 2019 · 123 citations · Full text

Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities

Jessica Lim, Rosalind Walley, Jiacheng Yuan et al. · Therapeutic Innovation & Regulatory Science · 2018 · 109 citations · Full text

Patient Selection, Historical Subject-level Data, Clinical Endpoint +19

Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias

Jessica Lim, Li Wang, Nicky Best et al. · Therapeutic Innovation & Regulatory Science · 2019 · 25 citations

Retrospective Cohort Study, Epidemiology, Health Policy +13

228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study

Hasan Tahir, Philip Mease, Iain B. McInnes et al. · Lara D. Veeken · 2015 · 24 citations · Full text

Inflammation, Rheumatology, Autoimmune Disease +14